Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial Letter

Industry Collaboration International Collaboration

cited authors

  • Verma, Subodh, Bhatt, Deepak L., Bain, Stephen C., Buse, John B., Mann, Johannes F. E., Marso, Steven P., Nauck, Michael A., Poulter, Neil R., Pratley, Richard E., Zinman, Bernard, Michelsen, Marie M., Fries, Tea Monk, Rasmussen, Soren, Leiter, Lawrence A., LEADER Trial Investigators

funding text

  • The LEADER trial was funded by Novo Nordisk.

authors

Publication Date

  • May 15, 2018

webpage

published in

category

start page

  • 2179

end page

  • 2183

volume

  • 137

issue

  • 20

WoS Citations

  • 5

WoS References

  • 5